ID   KCC2G_HUMAN             Reviewed;         558 AA.
AC   Q13555; O00561; O15378; Q13279; Q13282; Q13556; Q5SQZ3; Q5SQZ4;
AC   Q5SWX4; Q7KYX5; Q8N4I3; Q8NIA4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 3.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type II subunit gamma;
DE            Short=CaM kinase II subunit gamma;
DE            Short=CaMK-II subunit gamma;
DE            EC=2.7.11.17;
GN   Name=CAMK2G; Synonyms=CAMK, CAMK-II, CAMKG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-36.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), AND VARIANT
RP   PRO-36.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-315.
RX   PubMed=9240463; DOI=10.1006/bbrc.1997.6871;
RA   Breen M.A., Ashcroft S.J.;
RT   "Human islets of Langerhans express multiple isoforms of
RT   calcium/calmodulin-dependent protein kinase II.";
RL   Biochem. Biophys. Res. Commun. 236:473-478(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 23-558, AND ALTERNATIVE SPLICING
RP   (ISOFORM 6).
RX   PubMed=12032636; DOI=10.1007/s00125-002-0779-8;
RA   Gloyn A.L., Desai M., Clark A., Levy J.C., Holman R.R., Frayling T.M.,
RA   Hattersley A.T., Ashcroft S.J.;
RT   "Human calcium/calmodulin-dependent protein kinase II gamma: cloning,
RT   genomic structure and detection of variants in subjects with type II
RT   diabetes.";
RL   Diabetologia 45:580-583(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 66-436 (ISOFORM 10).
RX   PubMed=8449910;
RA   Nghiem P., Saati S.M., Martens C.L., Gardner P., Schulman H.;
RT   "Cloning and analysis of two new isoforms of multifunctional
RT   Ca2+/calmodulin-dependent protein kinase. Expression in multiple human
RT   tissues.";
RL   J. Biol. Chem. 268:5471-5479(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 302-497 (ISOFORMS 2 AND 4).
RX   PubMed=9060999; DOI=10.1016/S0167-4889(96)00141-3;
RA   Tombes R.M., Krystal G.W.;
RT   "Identification of novel human tumor cell-specific CaMK-II variants.";
RL   Biochim. Biophys. Acta 1355:281-292(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 326-432 (ISOFORMS 7; 8 AND 9).
RX   PubMed=7557101; DOI=10.1016/0016-5085(95)90594-4;
RA   Kwiatkowski A.P., McGill J.M.;
RT   "Human biliary epithelial cell line Mz-ChA-1 expresses new isoforms of
RT   calmodulin-dependent protein kinase II.";
RL   Gastroenterology 109:1316-1323(1995).
RN   [9]
RP   ENZYME REGULATION, SUBUNIT, AND AUTOPHOSPHORYLATION.
RX   PubMed=14722083; DOI=10.1074/jbc.M313597200;
RA   Gaertner T.R., Kolodziej S.J., Wang D., Kobayashi R., Koomen J.M.,
RA   Stoops J.K., Waxham M.N.;
RT   "Comparative analyses of the three-dimensional structures and
RT   enzymatic properties of alpha, beta, gamma and delta isoforms of Ca2+-
RT   calmodulin-dependent protein kinase II.";
RL   J. Biol. Chem. 279:12484-12494(2004).
RN   [10]
RP   FUNCTION IN SKELETAL MUSCLE, PHOSPHORYLATION AT THR-287, FUNCTION IN
RP   PHOSPHORYLATION OF PLN, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=16690701; DOI=10.1113/jphysiol.2006.111757;
RA   Rose A.J., Kiens B., Richter E.A.;
RT   "Ca2+-calmodulin-dependent protein kinase expression and signalling in
RT   skeletal muscle during exercise.";
RL   J. Physiol. (Lond.) 574:889-903(2006).
RN   [11]
RP   REVIEW ON FUNCTION IN SKELETAL MUSCLE.
RX   PubMed=15294044; DOI=10.1079/PNS2004335;
RA   Chin E.R.;
RT   "The role of calcium and calcium/calmodulin-dependent kinases in
RT   skeletal muscle plasticity and mitochondrial biogenesis.";
RL   Proc. Nutrit. Soc. 63:279-286(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311; SER-349; SER-352
RP   AND SER-419, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325
RP   (ISOFORMS 10; 2; 3; 5; 6; 7; 8 AND 9), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-338 (ISOFORM 9), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-287; SER-311; SER-352
RP   AND SER-419, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325
RP   (ISOFORMS 10; 2; 3; 7; 8 AND 9), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-287 AND SER-419, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-419, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 5-315 AND 426-556 IN COMPLEX
RP   WITH INHIBITOR.
RX   PubMed=20668654; DOI=10.1371/journal.pbio.1000426;
RA   Rellos P., Pike A.C., Niesen F.H., Salah E., Lee W.H., von Delft F.,
RA   Knapp S.;
RT   "Structure of the CaMKIIdelta/calmodulin complex reveals the molecular
RT   mechanism of CaMKII kinase activation.";
RL   PLoS Biol. 8:E1000426-E1000426(2010).
RN   [20]
RP   VARIANT PRO-292.
RX   PubMed=23033978; DOI=10.1056/NEJMoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P.,
RA   Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B.,
RA   Brunner H.G., Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that
CC       functions autonomously after Ca(2+)/calmodulin-binding and
CC       autophosphorylation, and is involved in sarcoplsamic reticulum
CC       Ca(2+) transport in skeletal muscle and may function in dendritic
CC       spine and synapse formation and neuronal plasticity. In slow-
CC       twitch muscles, is involved in regulation of sarcoplasmic
CC       reticulum (SR) Ca(2+) transport and in fast-twitch muscle
CC       participates in the control of Ca(2+) release from the SR through
CC       phosphorylation of the ryanodine receptor-coupling factor triadin.
CC       In neurons, may participate in the promotion of dendritic spine
CC       and synapse formation and maintenance of synaptic plasticity which
CC       enables long-term potentiation (LTP) and hippocampus-dependent
CC       learning. {ECO:0000269|PubMed:16690701}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves
CC       intrasteric autoinhibition and allows autophosphorylation of Thr-
CC       287 which turns the kinase in a constitutively active form and
CC       confers to the kinase a Ca(2+)-independent activity.
CC       {ECO:0000269|PubMed:14722083}.
CC   -!- SUBUNIT: CAMK2 is composed of 4 different chains: alpha (CAMK2A),
CC       beta (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different
CC       isoforms assemble into homo- or heteromultimeric holoenzymes
CC       composed of 12 subunits with two hexameric rings stacked one on
CC       top of the other. {ECO:0000269|PubMed:14722083,
CC       ECO:0000269|PubMed:20668654}.
CC   -!- INTERACTION:
CC       Q13554-3:CAMK2B; NbExp=4; IntAct=EBI-12020154, EBI-11523526;
CC       Q13557-8:CAMK2D; NbExp=4; IntAct=EBI-12020154, EBI-11534483;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-1383465, EBI-352572;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000305}; Peripheral membrane protein {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC       Name=1;
CC         IsoId=Q13555-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13555-2; Sequence=VSP_013349;
CC         Note=Contains a phosphoserine at position 325.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC       Name=3;
CC         IsoId=Q13555-3; Sequence=VSP_013350;
CC         Note=Contains a phosphoserine at position 325.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC       Name=4;
CC         IsoId=Q13555-4; Sequence=VSP_004778;
CC       Name=5;
CC         IsoId=Q13555-5; Sequence=VSP_032699, VSP_032700, VSP_004778;
CC         Note=Contains a phosphoserine at position 325.
CC         {ECO:0000244|PubMed:18691976};
CC       Name=6;
CC         IsoId=Q13555-6; Sequence=VSP_032699, VSP_035456;
CC         Note=Contains a phosphoserine at position 325.
CC         {ECO:0000244|PubMed:18691976};
CC       Name=7; Synonyms=gamma F;
CC         IsoId=Q13555-7; Sequence=VSP_013350, VSP_035456;
CC         Note=Contains a phosphoserine at position 325.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC       Name=8; Synonyms=gamma E;
CC         IsoId=Q13555-8; Sequence=VSP_013349, VSP_035456;
CC         Note=Contains a phosphoserine at position 325.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC       Name=9; Synonyms=gamma D;
CC         IsoId=Q13555-9; Sequence=VSP_013349, VSP_036027, VSP_035456;
CC         Note=Contains a phosphoserine at position 325. Contains a
CC         phosphoserine at position 338. {ECO:0000244|PubMed:18691976,
CC         ECO:0000244|PubMed:19369195};
CC       Name=10;
CC         IsoId=Q13555-10; Sequence=VSP_013350, VSP_004778;
CC         Note=Contains a phosphoserine at position 325.
CC         {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195};
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle.
CC       {ECO:0000269|PubMed:16690701}.
CC   -!- INDUCTION: Activity is induced in skeletal muscle during exercise.
CC       {ECO:0000269|PubMed:16690701}.
CC   -!- DOMAIN: The CAMK2 protein kinases contain a unique C-terminal
CC       subunit association domain responsible for oligomerization.
CC   -!- PTM: Autophosphorylation of Thr-287 following activation by
CC       Ca(2+)/calmodulin. Phosphorylation of Thr-287 locks the kinase
CC       into an activated state. {ECO:0000269|PubMed:16690701}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB61379.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL713896; CAI13789.1; -; Genomic_DNA.
DR   EMBL; AC022400; CAI13789.1; JOINED; Genomic_DNA.
DR   EMBL; AL596247; CAI13789.1; JOINED; Genomic_DNA.
DR   EMBL; AL713896; CAI13790.1; -; Genomic_DNA.
DR   EMBL; AC022400; CAI13790.1; JOINED; Genomic_DNA.
DR   EMBL; AL596247; CAI13790.1; JOINED; Genomic_DNA.
DR   EMBL; AL713896; CAI13791.1; -; Genomic_DNA.
DR   EMBL; AC022400; CAI13791.1; JOINED; Genomic_DNA.
DR   EMBL; AL596247; CAI13791.1; JOINED; Genomic_DNA.
DR   EMBL; AL596247; CAI13965.1; -; Genomic_DNA.
DR   EMBL; AC022400; CAI13965.1; JOINED; Genomic_DNA.
DR   EMBL; AL713896; CAI13965.1; JOINED; Genomic_DNA.
DR   EMBL; AL596247; CAI13966.1; -; Genomic_DNA.
DR   EMBL; AC022400; CAI13966.1; JOINED; Genomic_DNA.
DR   EMBL; AL713896; CAI13966.1; JOINED; Genomic_DNA.
DR   EMBL; AL596247; CAI13968.1; -; Genomic_DNA.
DR   EMBL; AC022400; CAI13968.1; JOINED; Genomic_DNA.
DR   EMBL; AL713896; CAI13968.1; JOINED; Genomic_DNA.
DR   EMBL; CH471083; EAW54532.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54536.1; -; Genomic_DNA.
DR   EMBL; BC034044; AAH34044.1; -; mRNA.
DR   EMBL; U66064; AAB80848.1; -; mRNA.
DR   EMBL; AH011636; AAM33514.1; -; Genomic_DNA.
DR   EMBL; L07043; AAB61379.1; ALT_INIT; mRNA.
DR   EMBL; U50359; AAB16864.1; -; mRNA.
DR   EMBL; U50360; AAB16865.1; -; mRNA.
DR   EMBL; U32472; AAA75201.1; -; mRNA.
DR   EMBL; U32473; AAA75202.1; -; mRNA.
DR   EMBL; U32509; AAA75203.1; -; mRNA.
DR   CCDS; CCDS7336.1; -. [Q13555-10]
DR   CCDS; CCDS7337.1; -. [Q13555-5]
DR   CCDS; CCDS7338.1; -. [Q13555-8]
DR   PIR; G01975; G01975.
DR   PIR; G01978; G01978.
DR   RefSeq; NP_001213.2; NM_001222.3. [Q13555-10]
DR   RefSeq; NP_001307827.1; NM_001320898.1.
DR   RefSeq; NP_751909.1; NM_172169.2. [Q13555-5]
DR   RefSeq; NP_751913.1; NM_172173.2.
DR   RefSeq; XP_005270258.1; XM_005270201.1. [Q13555-9]
DR   RefSeq; XP_005270260.1; XM_005270203.1. [Q13555-4]
DR   RefSeq; XP_006718056.1; XM_006717993.1. [Q13555-6]
DR   UniGene; Hs.523045; -.
DR   UniGene; Hs.654811; -.
DR   PDB; 2UX0; X-ray; 2.46 A; A/B/C/D/E/F=389-556.
DR   PDB; 2V7O; X-ray; 2.25 A; A=5-315.
DR   PDBsum; 2UX0; -.
DR   PDBsum; 2V7O; -.
DR   ProteinModelPortal; Q13555; -.
DR   SMR; Q13555; -.
DR   BioGrid; 107268; 44.
DR   DIP; DIP-51315N; -.
DR   IntAct; Q13555; 38.
DR   STRING; 9606.ENSP00000319060; -.
DR   BindingDB; Q13555; -.
DR   ChEMBL; CHEMBL3829; -.
DR   DrugBank; DB06616; Bosutinib.
DR   GuidetoPHARMACOLOGY; 1557; -.
DR   iPTMnet; Q13555; -.
DR   PhosphoSitePlus; Q13555; -.
DR   BioMuta; CAMK2G; -.
DR   DMDM; 62512173; -.
DR   EPD; Q13555; -.
DR   MaxQB; Q13555; -.
DR   PaxDb; Q13555; -.
DR   PeptideAtlas; Q13555; -.
DR   PRIDE; Q13555; -.
DR   DNASU; 818; -.
DR   Ensembl; ENST00000305762; ENSP00000307082; ENSG00000148660. [Q13555-4]
DR   Ensembl; ENST00000322635; ENSP00000315599; ENSG00000148660. [Q13555-5]
DR   Ensembl; ENST00000322680; ENSP00000319060; ENSG00000148660. [Q13555-8]
DR   Ensembl; ENST00000351293; ENSP00000277853; ENSG00000148660. [Q13555-10]
DR   GeneID; 818; -.
DR   KEGG; hsa:818; -.
DR   UCSC; uc001jvm.2; human. [Q13555-1]
DR   CTD; 818; -.
DR   DisGeNET; 818; -.
DR   GeneCards; CAMK2G; -.
DR   HGNC; HGNC:1463; CAMK2G.
DR   HPA; HPA040656; -.
DR   HPA; HPA051783; -.
DR   HPA; HPA051785; -.
DR   HPA; HPA053973; -.
DR   MIM; 602123; gene.
DR   neXtProt; NX_Q13555; -.
DR   OpenTargets; ENSG00000148660; -.
DR   PharmGKB; PA93; -.
DR   eggNOG; KOG0033; Eukaryota.
DR   eggNOG; ENOG410XNRX; LUCA.
DR   GeneTree; ENSGT00760000118944; -.
DR   HOVERGEN; HBG108055; -.
DR   InParanoid; Q13555; -.
DR   KO; K04515; -.
DR   PhylomeDB; Q13555; -.
DR   TreeFam; TF315229; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-399719; Trafficking of AMPA receptors.
DR   Reactome; R-HSA-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-HSA-442729; CREB phosphorylation through the activation of CaMKII.
DR   Reactome; R-HSA-442742; CREB phosphorylation through the activation of Ras.
DR   Reactome; R-HSA-442982; Ras activation uopn Ca2+ infux through NMDA receptor.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   SignaLink; Q13555; -.
DR   SIGNOR; Q13555; -.
DR   ChiTaRS; CAMK2G; human.
DR   EvolutionaryTrace; Q13555; -.
DR   GeneWiki; CAMK2G; -.
DR   GenomeRNAi; 818; -.
DR   PRO; PR:Q13555; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148660; -.
DR   ExpressionAtlas; Q13555; baseline and differential.
DR   Genevisible; Q13555; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004723; F:calcium-dependent protein serine/threonine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0006816; P:calcium ion transport; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0030073; P:insulin secretion; NAS:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0051259; P:protein oligomerization; IDA:BHF-UCL.
DR   GO; GO:0051924; P:regulation of calcium ion transport; TAS:UniProtKB.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:1901897; P:regulation of relaxation of cardiac muscle; IEA:Ensembl.
DR   GO; GO:0014733; P:regulation of skeletal muscle adaptation; TAS:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR013543; Ca/CaM-dep_prot_kinase-assoc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR032710; NTF2-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF08332; CaMKII_AD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54427; SSF54427; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Complete proteome; Developmental protein; Differentiation; Kinase;
KW   Membrane; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Sarcoplasmic reticulum;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    558       Calcium/calmodulin-dependent protein
FT                                kinase type II subunit gamma.
FT                                /FTId=PRO_0000086101.
FT   DOMAIN       14    272       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      20     28       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      283    292       Autoinhibitory domain.
FT   REGION      291    301       Calmodulin-binding. {ECO:0000250}.
FT   REGION      294    316       Calmodulin-binding.
FT   ACT_SITE    136    136       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      43     43       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     287    287       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:16690701}.
FT   MOD_RES     306    306       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     307    307       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000305}.
FT   MOD_RES     311    311       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     334    334       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11730}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     381    381       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P28652}.
FT   MOD_RES     384    384       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08413}.
FT   MOD_RES     387    387       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P28652}.
FT   MOD_RES     388    388       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P28652}.
FT   MOD_RES     419    419       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     484    484       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11730}.
FT   VAR_SEQ     315    315       S -> SVGRQSSAPASPAASAAGLAGQ (in isoform 5
FT                                and isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032699.
FT   VAR_SEQ     331    364       Missing (in isoform 3, isoform 7 and
FT                                isoform 10). {ECO:0000303|PubMed:7557101,
FT                                ECO:0000303|PubMed:8449910}.
FT                                /FTId=VSP_013350.
FT   VAR_SEQ     331    341       Missing (in isoform 2, isoform 8 and
FT                                isoform 9). {ECO:0000303|PubMed:7557101,
FT                                ECO:0000303|PubMed:9060999}.
FT                                /FTId=VSP_013349.
FT   VAR_SEQ     341    363       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032700.
FT   VAR_SEQ     351    364       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:7557101}.
FT                                /FTId=VSP_036027.
FT   VAR_SEQ     396    425       ARSPEGRSSRDRTAPSAGMQPQPSLCSSAM -> V (in
FT                                isoform 4, isoform 5 and isoform 10).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8449910,
FT                                ECO:0000303|PubMed:9060999}.
FT                                /FTId=VSP_004778.
FT   VAR_SEQ     397    398       RS -> APLRTGNGSSV (in isoform 6, isoform
FT                                7, isoform 8 and isoform 9).
FT                                {ECO:0000303|PubMed:7557101}.
FT                                /FTId=VSP_035456.
FT   VARIANT      36     36       S -> P (in dbSNP:rs17853266).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_042430.
FT   VARIANT     292    292       R -> P (found in a patient with severe
FT                                mental retardation, myopia, strabismus;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:23033978}.
FT                                /FTId=VAR_069390.
FT   CONFLICT    230    230       A -> T (in Ref. 6; AAB61379).
FT                                {ECO:0000305}.
FT   HELIX         9     13       {ECO:0000244|PDB:2V7O}.
FT   STRAND       14     22       {ECO:0000244|PDB:2V7O}.
FT   STRAND       26     33       {ECO:0000244|PDB:2V7O}.
FT   TURN         34     37       {ECO:0000244|PDB:2V7O}.
FT   STRAND       38     46       {ECO:0000244|PDB:2V7O}.
FT   HELIX        52     67       {ECO:0000244|PDB:2V7O}.
FT   STRAND       76     81       {ECO:0000244|PDB:2V7O}.
FT   STRAND       83     91       {ECO:0000244|PDB:2V7O}.
FT   HELIX        98    103       {ECO:0000244|PDB:2V7O}.
FT   HELIX       110    129       {ECO:0000244|PDB:2V7O}.
FT   HELIX       139    141       {ECO:0000244|PDB:2V7O}.
FT   STRAND      142    145       {ECO:0000244|PDB:2V7O}.
FT   STRAND      153    155       {ECO:0000244|PDB:2V7O}.
FT   HELIX       178    180       {ECO:0000244|PDB:2V7O}.
FT   HELIX       183    187       {ECO:0000244|PDB:2V7O}.
FT   HELIX       194    209       {ECO:0000244|PDB:2V7O}.
FT   HELIX       219    227       {ECO:0000244|PDB:2V7O}.
FT   HELIX       237    240       {ECO:0000244|PDB:2V7O}.
FT   HELIX       243    252       {ECO:0000244|PDB:2V7O}.
FT   TURN        257    259       {ECO:0000244|PDB:2V7O}.
FT   HELIX       263    266       {ECO:0000244|PDB:2V7O}.
FT   HELIX       270    273       {ECO:0000244|PDB:2V7O}.
FT   HELIX       275    278       {ECO:0000244|PDB:2V7O}.
FT   HELIX       285    301       {ECO:0000244|PDB:2V7O}.
FT   HELIX       390    397       {ECO:0000244|PDB:2UX0}.
FT   HELIX       427    443       {ECO:0000244|PDB:2UX0}.
FT   HELIX       446    452       {ECO:0000244|PDB:2UX0}.
FT   STRAND      453    460       {ECO:0000244|PDB:2UX0}.
FT   HELIX       462    464       {ECO:0000244|PDB:2UX0}.
FT   STRAND      468    470       {ECO:0000244|PDB:2UX0}.
FT   HELIX       471    481       {ECO:0000244|PDB:2UX0}.
FT   TURN        482    485       {ECO:0000244|PDB:2UX0}.
FT   STRAND      490    501       {ECO:0000244|PDB:2UX0}.
FT   STRAND      506    518       {ECO:0000244|PDB:2UX0}.
FT   STRAND      524    538       {ECO:0000244|PDB:2UX0}.
FT   STRAND      541    550       {ECO:0000244|PDB:2UX0}.
SQ   SEQUENCE   558 AA;  62609 MW;  38D4112C2FDBD44C CRC64;
     MATTATCTRF TDDYQLFEEL GKGAFSVVRR CVKKTSTQEY AAKIINTKKL SARDHQKLER
     EARICRLLKH PNIVRLHDSI SEEGFHYLVF DLVTGGELFE DIVAREYYSE ADASHCIHQI
     LESVNHIHQH DIVHRDLKPE NLLLASKCKG AAVKLADFGL AIEVQGEQQA WFGFAGTPGY
     LSPEVLRKDP YGKPVDIWAC GVILYILLVG YPPFWDEDQH KLYQQIKAGA YDFPSPEWDT
     VTPEAKNLIN QMLTINPAKR ITADQALKHP WVCQRSTVAS MMHRQETVEC LRKFNARRKL
     KGAILTTMLV SRNFSAAKSL LNKKSDGGVK KRKSSSSVHL MPQSNNKNSL VSPAQEPAPL
     QTAMEPQTTV VHNATDGIKG STESCNTTTE DEDLKARSPE GRSSRDRTAP SAGMQPQPSL
     CSSAMRKQEI IKITEQLIEA INNGDFEAYT KICDPGLTSF EPEALGNLVE GMDFHKFYFE
     NLLSKNSKPI HTTILNPHVH VIGEDAACIA YIRLTQYIDG QGRPRTSQSE ETRVWHRRDG
     KWLNVHYHCS GAPAAPLQ
//
